[Federal Register Volume 89, Number 113 (Tuesday, June 11, 2024)]
[Notices]
[Pages 49181-49182]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-12733]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Alcohol Abuse and Alcoholism; Notice of 
Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Special Emphasis Panel; NIAAA Special Emphasis Panel for 
Member Conflict Applications.
    Date: July 1, 2024.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute on 
Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 
20892 (Virtual Meeting).
    Contact Person: Luis Espinoza, Ph.D., Scientific Review Officer, 
Extramural Project Review Branch, Office of Extramural Activities, 
National Institute on Alcohol Abuse and Alcoholism, National 
Institutes of Health, 6700B Rockledge Drive, Room 2109, Bethesda, MD 
20892, (301) 443-8599, [email protected].

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Special Emphasis Panel; NIAAA Fellowship Review Panel.
    Date: July 9, 2024.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute on 
Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 
20892 (Virtual Meeting).
    Contact Person: Luis Espinoza, Ph.D., Scientific Review Officer, 
Extramural Project Review Branch, Office of Extramural Activities, 
National Institute on Alcohol

[[Page 49182]]

Abuse and Alcoholism, National Institutes of Health, 6700B Rockledge 
Drive, Room 2109, Bethesda, MD 20892, (301) 443-8599, 
[email protected].

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Special Emphasis Panel; RFA AA-24-004 and 005--Limited 
Competition: Alcohol-associated Hepatitis Clinical Network--
Integrated Treatment Clinical Trials.
    Date: July 19, 2024.
    Time: 11:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute on 
Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 
20892 (Virtual Meeting).
    Contact Person: Ranga Srinivas, Ph.D., Chief, Extramural Project 
Review Branch, National Institute on Alcohol Abuse and Alcoholism, 
National Institutes of Health, 6700B Rockledge Drive, Room 2114, 
Bethesda, MD 20892, (301) 451-2067, [email protected].

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Special Emphasis Panel; RFA-AA-23-004--Comprehensive 
Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional).
    Date: July 23-24, 2024.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute on 
Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 
20892 (Virtual Meeting).
    Contact Person: Ranga Srinivas, Ph.D., Chief, Extramural Project 
Review Branch, National Institute on Alcohol Abuse and Alcoholism, 
National Institutes of Health, 6700B Rockledge Drive, Room 2114, 
Bethesda, MD 20892, (301) 451-2067, [email protected].

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Special Emphasis Panel; RFA AA-24-002 High-Throughput 
Screening Platform for Discovery of and PAR-22-103 Investigational 
New Drug (IND)-enabling and Early-Stage Development of Medications 
to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage 
(UT1/UT2)
    Date: July 25, 2024.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute on 
Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 
20892 (Virtual Meeting).
    Contact Person: Luis Espinoza, Ph.D., Scientific Review Officer, 
Extramural Project Review Branch, Office of Extramural Activities, 
National Institute on Alcohol Abuse and Alcoholism, National 
Institutes of Health, 6700B Rockledge Drive, Room 2109, Bethesda, MD 
20892, (301) 443-8599, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.273, 
Alcohol Research Programs, National Institutes of Health, HHS)

    Dated: June 6, 2024.
David W Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2024-12733 Filed 6-10-24; 8:45 am]
BILLING CODE 4140-01-P